Mass spectrometry for peptide identity

Mass spectrometry (MS) is the cornerstone of peptide identity confirmation. While HPLC purity tells you what proportion of the sample is the main peak, mass spectrometry tells you what that main peak is. Together, the two techniques form the analytical backbone of any credible peptide CoA.

The principle

Mass spectrometry ionises the peptide and measures the mass-to-charge ratio (m/z) of the resulting ions. From the m/z, the analyst computes the molecular weight (MW) of the parent molecule. If the measured MW matches the theoretical MW predicted from the peptide’s sequence (within instrument tolerance), the identity is confirmed.

For a peptide of known sequence, the theoretical monoisotopic mass is computed by summing the residue masses (using monoisotopic atomic weights) and subtracting (N–1) × 18.0106 (for the water lost in each peptide bond formation), where N is the number of residues. For example, BPC-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) has a theoretical monoisotopic mass of 1418.69 Da. A MS measurement of 1418.7 ± 0.5 Da confirms identity at typical instrument resolution.

Common ionisation modes

Two ionisation techniques dominate peptide mass spectrometry:

• Electrospray ionisation (ESI): the peptide solution is sprayed through a charged capillary, generating multiply-charged ions in positive mode. The mass spectrum shows a series of peaks corresponding to different charge states ([M+H]+, [M+2H]2+, [M+3H]3+, etc.). The molecular weight is deconvoluted from the charge envelope.
• Matrix-assisted laser desorption ionisation (MALDI): the peptide is co-crystallised with a UV-absorbing matrix (commonly α-cyano-4-hydroxycinnamic acid for peptides) and ionised by a laser pulse. MALDI typically produces singly-charged ions, simplifying interpretation.
• Steen, H., Mann, M. (2004). The ABC of peptide sequencing. Nature Reviews Molecular Cell Biology, 5(9), 699-711. DOI: 10.1038/nrm1468.

For research-grade peptide CoAs, ESI-MS coupled to a quadrupole, time-of-flight (TOF), or Orbitrap mass analyser is most common. The mass accuracy depends on the analyser: low-resolution quadrupole instruments give ±0.5 Da; high-resolution TOF and Orbitrap give ±0.01 Da (10 ppm or better).

What the mass spectrum tells you

A clean peptide mass spectrum shows:

• One or more peaks corresponding to the expected charge states of the parent peptide;
• Calculated parent mass matching theoretical mass within tolerance;
• Minimal additional peaks attributable to common modifications or impurities.

Common findings beyond the parent

A serious mass spec analysis will flag any of the following secondary peaks if present:

• Oxidation (+16 Da): oxidation of methionine, tryptophan, or cysteine residues. Common in peptides exposed to ambient oxygen during synthesis or storage.
• Deamidation (+1 Da): conversion of asparagine to aspartate or glutamine to glutamate. Slow but occurs at neutral pH over time.
• Truncation (smaller peaks): peptides missing one or more N-terminal or C-terminal residues. Common synthesis byproducts.
• Sodium or potassium adducts (+22, +38 Da): common artefacts from solvent or salt residues. Usually not concerning for the underlying peptide, but should be noted.
• TFA adducts (+114 Da): from residual trifluoroacetic acid used in synthesis purification.
• Acetylation or other modifications (+42 Da for acetyl): intentional in some peptides (e.g. AHK-Cu is N-acetylated); unintentional in others.

Tandem mass spectrometry (MS/MS)

For sequence confirmation beyond mass, tandem MS (MS/MS) fragments the parent ion and analyses the resulting fragments. The fragmentation pattern — particularly the b-ion and y-ion series — directly reads out the sequence from the N-terminus and C-terminus. MS/MS is the gold standard for sequence verification and is used when ambiguity exists or for peptides with isomeric sequences (e.g. leucine vs isoleucine, which have identical mass).

For routine quality control of established peptides, mass-only analysis is usually sufficient; for novel peptides or first-batch verification, MS/MS provides the highest confidence.

How to read MS data on a CoA

A serious CoA will include:

• The mass spectrum image (annotated with peak m/z values);
• The theoretical mass for the peptide (calculated from sequence);
• The observed mass (measured experimentally);
• The mass error in Da or ppm, with an acceptance criterion (e.g. “within ±0.5 Da”);
• Identification of any minor peaks present.

If the observed mass differs from theoretical by more than the stated tolerance, the identity is not confirmed and the lot should not be released. A 16 Da deviation, for example, strongly suggests oxidation; a 1 Da deviation suggests deamidation. The analyst should be able to explain any deviation.

The combined HPLC + MS standard

HPLC purity ≥99% combined with mass-confirmed identity within ±0.5 Da is the industry standard for research-grade peptides. Either measurement alone is insufficient:

• HPLC purity without MS confirms purity but not identity — two different peptides with similar hydrophobicity can co-elute and be reported as “99% pure” while being entirely incorrect.

References & further reading

• Aebersold, R., Mann, M. (2003). Mass spectrometry-based proteomics. Nature, 422(6928), 198–207. DOI: 10.1038/nature01511.
• Domon, B., Aebersold, R. (2006). Mass spectrometry and protein analysis. Science, 312(5771), 212–217.
• Han, H., Xia, Y., McLuckey, S. A. (2008). Ion trap collisional activation of c and z• ions formed via gas-phase ion/ion electron-transfer dissociation. Journal of Proteome Research, 7(8), 3236–3244.
• Karas, M., Hillenkamp, F. (1988). Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry, 60(20), 2299-2301. DOI: 10.1021/ac00171a028.
• Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., Whitehouse, C. M. (1989). Electrospray ionization for mass spectrometry of large biomolecules. Science, 246(4926), 64-71. DOI: 10.1126/science.2675315.
• Annesley, T. M. (2003). Ion suppression in mass spectrometry. Clinical Chemistry, 49(7), 1041-1044. DOI: 10.1373/49.7.1041.
• Olsen, J. V., Mann, M. (2013). Status of large-scale analysis of post-translational modifications by mass spectrometry. Molecular & Cellular Proteomics, 12(12), 3444-3452. DOI: 10.1074/mcp.O113.034181.
• Makarov, A. (2000). Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis. Analytical Chemistry, 72(6), 1156-1162. DOI: 10.1021/ac991131p.